Neoepitopes-based vaccines: challenges and perspectives
- 1 February 2019
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 108, 55-60
Abstract
No abstract availableKeywords
Funding Information
- Institut national du cancer INCA (PRT-K2017-072)
- Ligue Contre le Cancer
- University of Lyon
This publication has 41 references indexed in Scilit:
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive MelanomaJournal of Clinical Oncology, 2013
- Properties of MHC Class I Presented Peptides That Enhance ImmunogenicityPLOS Computational Biology, 2013
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survivalNature Medicine, 2012
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current PerspectiveCancer Research, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingNature, 2012
- Cytokines in Cancer ImmunotherapyCancers, 2011
- Viruses as vaccine vectors for infectious diseases and cancerNature Reviews Microbiology, 2009
- Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccinesNature Reviews Cancer, 2008
- Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8Science, 2004